Verona Pharma
NEWS
Verona Pharma plc, a biopharmaceutical company focused on respiratory diseases, announces positive Phase 2 data with a dry powder inhaler formulation of its lead development product, ensifentrine, for the maintenance treatment of chronic obstructive pulmonary disease.
Biotech and pharma companies tap new members of executive leadership teams and boards.
Biotech and pharma companies from across the globe share data and news in a weekly roundup.
Biopharma companies begin 2019 with a flurry of hiring to fill executive leadership spots, including Dermavant, UroGen, Melinta, Translate Bio, and more.
JOBS
IN THE PRESS